Skip to main content
Top
Published in: BMC Immunology 1/2008

Open Access 01-12-2008 | Research article

Streptococcus pneumoniae stabilizes tumor necrosis factor α mRNA through a pathway dependent on p38 MAPK but independent of Toll-like receptors

Authors: Trine H Mogensen, Randi S Berg, Lars Østergaard, Søren R Paludan

Published in: BMC Immunology | Issue 1/2008

Login to get access

Abstract

Background

Streptococcus pneumoniae is a human pathogenic bacteria and a major cause of severe invasive diseases, including pneumonia, bacteremia, and meningitis. Infections with S. pneumoniae evoke a strong inflammatory response, which plays a major role in the pathogenesis of pneumococcal disease.

Results

In this study, we have examined how S. pneumoniae affects expression of the inflammatory cytokine tumor necrosis factor (TNF) α, and the molecular mechanisms involved. Secretion of TNF-α was strongly induced by S. pneumoniae, which was able to stabilize TNF-α mRNA through a mechanism dependent on the viability of the bacteria as well as the adenylate uridylate-rich elements in the 3'untranslated region of TNF-α mRNA. The ability of S. pneumoniae to stabilize TNF-α mRNA was dependent on the mitogen-activated protein kinase (MAPK) p38 whereas inhibition of Toll-like receptor signaling via MyD88 did not affect S. pneumoniae- induced mRNA stabilization. P38 was activated through a pathway involving the upstream kinase transforming growth factor-activated kinase 1 and MAPK kinase 3.

Conclusion

Thus, S. pneumoniae stabilizes TNF-α mRNA through a pathway dependent on p38 but independent of Toll-like receptors. Production of TNF-α may contribute significantly to the inflammatory response raised during pneumococcal infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Koedel U, Scheld WM, Pfister HW: Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis. 2002, 2: 721-736. 10.1016/S1473-3099(02)00450-4.CrossRefPubMed Koedel U, Scheld WM, Pfister HW: Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis. 2002, 2: 721-736. 10.1016/S1473-3099(02)00450-4.CrossRefPubMed
2.
go back to reference Obaro S, Adegbola R: The pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol. 2002, 51: 98-104.CrossRefPubMed Obaro S, Adegbola R: The pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol. 2002, 51: 98-104.CrossRefPubMed
3.
go back to reference Albiger B, Dahlberg S, Sandgren A, Wartha F, Beiter K, Katsuragi H, et al.: Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell Microbiol. 2007, 9: 633-644. 10.1111/j.1462-5822.2006.00814.x.CrossRefPubMed Albiger B, Dahlberg S, Sandgren A, Wartha F, Beiter K, Katsuragi H, et al.: Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell Microbiol. 2007, 9: 633-644. 10.1111/j.1462-5822.2006.00814.x.CrossRefPubMed
4.
go back to reference Parsons HK, Dockrell DH: The burden of invasive pneumococcal disease and the potential for reduction by immunisation. Int J Antimicrob Agents. 2002, 19: 85-93. 10.1016/S0924-8579(01)00491-5.CrossRefPubMed Parsons HK, Dockrell DH: The burden of invasive pneumococcal disease and the potential for reduction by immunisation. Int J Antimicrob Agents. 2002, 19: 85-93. 10.1016/S0924-8579(01)00491-5.CrossRefPubMed
5.
go back to reference Moore LJ, Pridmore AC, Lee ME, Read RC: Induction of pro-inflammatory cytokine release by human macrophages during exposure of Streptococcus pneumoniae to penicillin is influenced by minimum inhibitory concentration ratio. Int J Antimicrob Agents. 2005, 26: 188-196. 10.1016/j.ijantimicag.2005.06.006.CrossRefPubMed Moore LJ, Pridmore AC, Lee ME, Read RC: Induction of pro-inflammatory cytokine release by human macrophages during exposure of Streptococcus pneumoniae to penicillin is influenced by minimum inhibitory concentration ratio. Int J Antimicrob Agents. 2005, 26: 188-196. 10.1016/j.ijantimicag.2005.06.006.CrossRefPubMed
6.
go back to reference Clark IA: How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev. 2007, 18: 335-343. 10.1016/j.cytogfr.2007.04.002.CrossRefPubMed Clark IA: How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev. 2007, 18: 335-343. 10.1016/j.cytogfr.2007.04.002.CrossRefPubMed
7.
go back to reference Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al.: Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001, 345: 1098-1104. 10.1056/NEJMoa011110.CrossRefPubMed Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al.: Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001, 345: 1098-1104. 10.1056/NEJMoa011110.CrossRefPubMed
8.
go back to reference Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, et al.: Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 1993, 364: 798-802. 10.1038/364798a0.CrossRefPubMed Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, et al.: Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 1993, 364: 798-802. 10.1038/364798a0.CrossRefPubMed
9.
go back to reference Kirby AC, Raynes JG, Kaye PM: The role played by tumor necrosis factor during localized and systemic infection with Streptococcus pneumoniae. J Infect Dis. 2005, 191: 1538-1547. 10.1086/429296.CrossRefPubMed Kirby AC, Raynes JG, Kaye PM: The role played by tumor necrosis factor during localized and systemic infection with Streptococcus pneumoniae. J Infect Dis. 2005, 191: 1538-1547. 10.1086/429296.CrossRefPubMed
10.
go back to reference Tsao N, Chang WW, Liu CC, Lei HY: Development of hematogenous pneumococcal meningitis in adult mice: the role of TNF-alpha. FEMS Immunol Med Microbiol. 2002, 32: 133-140.PubMed Tsao N, Chang WW, Liu CC, Lei HY: Development of hematogenous pneumococcal meningitis in adult mice: the role of TNF-alpha. FEMS Immunol Med Microbiol. 2002, 32: 133-140.PubMed
11.
go back to reference Piecyk M, Wax S, Beck AR, Kedersha N, Gupta M, Maritim B, et al.: TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J. 2000, 19: 4154-4163. 10.1093/emboj/19.15.4154.PubMedCentralCrossRefPubMed Piecyk M, Wax S, Beck AR, Kedersha N, Gupta M, Maritim B, et al.: TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J. 2000, 19: 4154-4163. 10.1093/emboj/19.15.4154.PubMedCentralCrossRefPubMed
12.
go back to reference Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G: Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity. 1999, 10: 387-398. 10.1016/S1074-7613(00)80038-2.CrossRefPubMed Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G: Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity. 1999, 10: 387-398. 10.1016/S1074-7613(00)80038-2.CrossRefPubMed
13.
go back to reference Anderson P, Phillips K, Stoecklin G, Kedersha N: Post-transcriptional regulation of proinflammatory proteins. J Leukoc Biol. 2004, 76: 42-47. 10.1189/jlb.1103536.CrossRefPubMed Anderson P, Phillips K, Stoecklin G, Kedersha N: Post-transcriptional regulation of proinflammatory proteins. J Leukoc Biol. 2004, 76: 42-47. 10.1189/jlb.1103536.CrossRefPubMed
14.
go back to reference Zhang T, Kruys V, Huez G, Gueydan C: AU-rich element-mediated translational control: complexity and multiple activities of trans-activating factors. Biochem Soc Trans. 2002, 30: 952-958. 10.1042/BST0300952.CrossRefPubMed Zhang T, Kruys V, Huez G, Gueydan C: AU-rich element-mediated translational control: complexity and multiple activities of trans-activating factors. Biochem Soc Trans. 2002, 30: 952-958. 10.1042/BST0300952.CrossRefPubMed
15.
go back to reference Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell. 2006, 124: 783-801. 10.1016/j.cell.2006.02.015.CrossRefPubMed Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell. 2006, 124: 783-801. 10.1016/j.cell.2006.02.015.CrossRefPubMed
16.
go back to reference Mogensen TH, Paludan SR, Kilian M, Ostergaard L: Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J Leukoc Biol. 2006, 80: 267-277. 10.1189/jlb.1105626.CrossRefPubMed Mogensen TH, Paludan SR, Kilian M, Ostergaard L: Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J Leukoc Biol. 2006, 80: 267-277. 10.1189/jlb.1105626.CrossRefPubMed
17.
go back to reference Moore LJ, Pridmore AC, Dower SK, Read RC: Penicillin enhances the toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae. J Infect Dis. 2003, 188: 1040-1048. 10.1086/378238.CrossRefPubMed Moore LJ, Pridmore AC, Dower SK, Read RC: Penicillin enhances the toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae. J Infect Dis. 2003, 188: 1040-1048. 10.1086/378238.CrossRefPubMed
18.
go back to reference Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D: Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol. 1999, 163: 1-5.PubMed Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D: Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol. 1999, 163: 1-5.PubMed
19.
go back to reference Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, et al.: Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci USA. 2003, 100: 1966-1971. 10.1073/pnas.0435928100.PubMedCentralCrossRefPubMed Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, et al.: Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci USA. 2003, 100: 1966-1971. 10.1073/pnas.0435928100.PubMedCentralCrossRefPubMed
20.
go back to reference Branger J, Knapp S, Weijer S, Leemans JC, Pater JM, Speelman P, et al.: Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun. 2004, 72: 788-794. 10.1128/IAI.72.2.788-794.2004.PubMedCentralCrossRefPubMed Branger J, Knapp S, Weijer S, Leemans JC, Pater JM, Speelman P, et al.: Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun. 2004, 72: 788-794. 10.1128/IAI.72.2.788-794.2004.PubMedCentralCrossRefPubMed
21.
go back to reference Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol. 2004, 4: 499-511. 10.1038/nri1391.CrossRefPubMed Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol. 2004, 4: 499-511. 10.1038/nri1391.CrossRefPubMed
22.
go back to reference Koedel U, Rupprecht T, Angele B, Heesemann J, Wagner H, Pfister HW, et al.: MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS. Brain. 2004, 127: 1437-1445. 10.1093/brain/awh171.CrossRefPubMed Koedel U, Rupprecht T, Angele B, Heesemann J, Wagner H, Pfister HW, et al.: MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS. Brain. 2004, 127: 1437-1445. 10.1093/brain/awh171.CrossRefPubMed
23.
go back to reference Wellmer A, Zysk G, Gerber J, Kunst T, Von Mering M, Bunkowski S, et al.: Decreased virulence of a pneumolysin-deficient strain of Streptococcus pneumoniae in murine meningitis. Infect Immun. 2002, 70: 6504-6508. 10.1128/IAI.70.11.6504-6508.2002.PubMedCentralCrossRefPubMed Wellmer A, Zysk G, Gerber J, Kunst T, Von Mering M, Bunkowski S, et al.: Decreased virulence of a pneumolysin-deficient strain of Streptococcus pneumoniae in murine meningitis. Infect Immun. 2002, 70: 6504-6508. 10.1128/IAI.70.11.6504-6508.2002.PubMedCentralCrossRefPubMed
24.
go back to reference Inohara N, Chamaillard , McDonald C, Nunez G: NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem. 2005, 74: 355-383. 10.1146/annurev.biochem.74.082803.133347.CrossRefPubMed Inohara N, Chamaillard , McDonald C, Nunez G: NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem. 2005, 74: 355-383. 10.1146/annurev.biochem.74.082803.133347.CrossRefPubMed
25.
go back to reference Opitz B, Puschel A, Schmeck B, Hocke AC, Rosseau S, Hammerschmidt S, et al.: Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem. 2004, 279: 36426-36432. 10.1074/jbc.M403861200.CrossRefPubMed Opitz B, Puschel A, Schmeck B, Hocke AC, Rosseau S, Hammerschmidt S, et al.: Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem. 2004, 279: 36426-36432. 10.1074/jbc.M403861200.CrossRefPubMed
26.
go back to reference Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al.: A Toll-like receptor recognizes bacterial DNA. Nature. 2000, 408: 740-745. 10.1038/35047123.CrossRefPubMed Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al.: A Toll-like receptor recognizes bacterial DNA. Nature. 2000, 408: 740-745. 10.1038/35047123.CrossRefPubMed
27.
go back to reference Windheim M, Lang C, Peggie M, Plater LA, Cohen P: Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. Biochem J. 2007, 404: 179-190. 10.1042/BJ20061704.PubMedCentralCrossRefPubMed Windheim M, Lang C, Peggie M, Plater LA, Cohen P: Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. Biochem J. 2007, 404: 179-190. 10.1042/BJ20061704.PubMedCentralCrossRefPubMed
28.
go back to reference Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, et al.: Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol. 2006, 26: 2399-2407. 10.1128/MCB.26.6.2399-2407.2006.PubMedCentralCrossRefPubMed Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, et al.: Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol. 2006, 26: 2399-2407. 10.1128/MCB.26.6.2399-2407.2006.PubMedCentralCrossRefPubMed
29.
go back to reference Brennan CM, Steitz JA: HuR and mRNA stability. Cell Mol Life Sci. 2001, 58: 266-277. 10.1007/PL00000854.CrossRefPubMed Brennan CM, Steitz JA: HuR and mRNA stability. Cell Mol Life Sci. 2001, 58: 266-277. 10.1007/PL00000854.CrossRefPubMed
30.
go back to reference Rajasingh J, Bord E, Luedemann C, Asai J, Hamada H, Thorne T, et al.: IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. FASEB J. 2006, 20: 2112-2114. 10.1096/fj.06-6084fje.CrossRefPubMed Rajasingh J, Bord E, Luedemann C, Asai J, Hamada H, Thorne T, et al.: IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. FASEB J. 2006, 20: 2112-2114. 10.1096/fj.06-6084fje.CrossRefPubMed
31.
go back to reference Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T, et al.: Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol. 2005, 6: 1087-1095. 10.1038/ni1255.CrossRefPubMed Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T, et al.: Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol. 2005, 6: 1087-1095. 10.1038/ni1255.CrossRefPubMed
32.
go back to reference Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, Hayden MS, et al.: TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 2005, 19: 2668-2681. 10.1101/gad.1360605.PubMedCentralCrossRefPubMed Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, Hayden MS, et al.: TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 2005, 19: 2668-2681. 10.1101/gad.1360605.PubMedCentralCrossRefPubMed
33.
go back to reference Kumar A, Takada Y, Boriek AM, Aggarwal BB: Nuclear factor-kappaB: its role in health and disease. J Mol Med. 2004, 82: 434-448. 10.1007/s00109-004-0555-y.CrossRefPubMed Kumar A, Takada Y, Boriek AM, Aggarwal BB: Nuclear factor-kappaB: its role in health and disease. J Mol Med. 2004, 82: 434-448. 10.1007/s00109-004-0555-y.CrossRefPubMed
34.
go back to reference Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ: TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 2001, 412: 346-351. 10.1038/35085597.CrossRefPubMed Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ: TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 2001, 412: 346-351. 10.1038/35085597.CrossRefPubMed
35.
go back to reference Behera AK, Hildebrand E, Uematsu S, Akira S, Coburn J, Hu LT: Identification of a TLR-independent pathway for Borrelia burgdorferi-induced expression of matrix metalloproteinases and inflammatory mediators through binding to integrin alpha 3 beta 1. J Immunol. 2006, 177: 657-664.CrossRefPubMed Behera AK, Hildebrand E, Uematsu S, Akira S, Coburn J, Hu LT: Identification of a TLR-independent pathway for Borrelia burgdorferi-induced expression of matrix metalloproteinases and inflammatory mediators through binding to integrin alpha 3 beta 1. J Immunol. 2006, 177: 657-664.CrossRefPubMed
36.
go back to reference Kumar A, Zhang J, Yu FS: Innate immune response of corneal epithelial cells to Staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion. Invest Ophthalmol Vis Sci. 2004, 45: 3513-3522. 10.1167/iovs.04-0467.PubMedCentralCrossRefPubMed Kumar A, Zhang J, Yu FS: Innate immune response of corneal epithelial cells to Staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion. Invest Ophthalmol Vis Sci. 2004, 45: 3513-3522. 10.1167/iovs.04-0467.PubMedCentralCrossRefPubMed
37.
go back to reference Dean JL, Sully G, Clark AR, Saklatvala J: The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell Signal. 2004, 16: 1113-1121. 10.1016/j.cellsig.2004.04.006.CrossRefPubMed Dean JL, Sully G, Clark AR, Saklatvala J: The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell Signal. 2004, 16: 1113-1121. 10.1016/j.cellsig.2004.04.006.CrossRefPubMed
38.
go back to reference Han J, Brown T, Beutler B: Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med. 1990, 171: 465-475. 10.1084/jem.171.2.465.CrossRefPubMed Han J, Brown T, Beutler B: Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med. 1990, 171: 465-475. 10.1084/jem.171.2.465.CrossRefPubMed
39.
go back to reference Willeaume V, Kruys V, Mijatovic T, Huez G: Tumor necrosis factor-alpha production induced by viruses and by lipopolysaccharides in macrophages: similarities and differences. J Inflamm. 1995, 46: 1-12.PubMed Willeaume V, Kruys V, Mijatovic T, Huez G: Tumor necrosis factor-alpha production induced by viruses and by lipopolysaccharides in macrophages: similarities and differences. J Inflamm. 1995, 46: 1-12.PubMed
40.
go back to reference Paludan SR, Ellermann-Eriksen S, Kruys V, Mogensen SC: Expression of TNF-alpha by herpes simplex virus-infected macrophages is regulated by a dual mechanism: transcriptional regulation by NF-kappa B and activating transcription factor 2/Jun and translational regulation through the AU-rich region of the 3' untranslated region. J Immunol. 2001, 167: 2202-2208.CrossRefPubMed Paludan SR, Ellermann-Eriksen S, Kruys V, Mogensen SC: Expression of TNF-alpha by herpes simplex virus-infected macrophages is regulated by a dual mechanism: transcriptional regulation by NF-kappa B and activating transcription factor 2/Jun and translational regulation through the AU-rich region of the 3' untranslated region. J Immunol. 2001, 167: 2202-2208.CrossRefPubMed
Metadata
Title
Streptococcus pneumoniae stabilizes tumor necrosis factor α mRNA through a pathway dependent on p38 MAPK but independent of Toll-like receptors
Authors
Trine H Mogensen
Randi S Berg
Lars Østergaard
Søren R Paludan
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2008
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/1471-2172-9-52

Other articles of this Issue 1/2008

BMC Immunology 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.